Liquidia Corporation
LQDANASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 23, 2026 close
- Market cap
- $4.32B
- P/E (TTM)
- 31.20
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $21.94$93.61
- Volume (live)
- -
- Avg. volume (3M)
- 5.38M
Liquidia (LQDA) Stock Price & Financial Analysis
Liquidia Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $38.69 - $42.83 |
|---|---|
| 52-Week High | $93.61 |
| 52-Week Low | $21.94 |
| Open | $39.86 |
| Volume (last close) | 3.81M |
| Average Volume (3M) | 5.38M |
| Revenue (TTM) | 450.91M |
|---|---|
| Net Income (TTM) | 138.61M |
| Free Cash Flow (TTM) | 60.51M |
| EPS (TTM) | $1.43 |
| Profit Margin | 30.74% |
| Operating Margin | 37.39% |
| Return on Equity (ROE) | 71.04% |
| Debt to Equity | 0.66 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 4.32B |
|---|---|
| Shares Outstanding | 101.40M |
| P/E Ratio (TTM) | 31.20 |
| Price to Sales (P/S) | 9.59 |
| Price to Book (P/B) | 22.16 |
| EV/EBITDA | 22.08 |
| 50-Day MA | $58.30 |
|---|---|
| 200-Day MA | $53.95 |
| 1-Year Change | +80.25% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Liquidia at a Glance
As of the Oct 23, 2026 close, Liquidia (LQDA) has a market capitalization of $4.32B. The stock trades at 31.2× trailing earnings and 9.6× sales. Over the trailing twelve months it earned $138.61M on revenue of $450.91M (a 30.7% profit margin) and generated $60.51M of free cash flow. Revenue grew 2233.7% year over year.
As of its latest reported balance sheet, it holds $284.18M in cash and securities against $128.94M of debt, a net cash position of $155.24M.
Liquidia does not currently pay a dividend.
The share price is up 80.2% over the past year. At $42.65 (the Oct 23, 2026 close) it sits within its 52-week range of $21.94 to $93.61, below its 200-day moving average of $53.95.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $53.13, 24.6% above the Oct 23, 2026 close.
Frequently Asked Questions About Liquidia
What is the current stock price for LQDA?
As of the Oct 23, 2026 close, LQDA stock trades at $42.65. The 52-week range is $21.94–$93.61, with a day range of $38.69–$42.83.
What is the P/E ratio for LQDA?
As of the Oct 23, 2026 close, Liquidia's trailing twelve-month (TTM) P/E ratio is 31.2, meaning investors pay $31.2 for every $1 of annual earnings. Liquidia operates in the Healthcare sector.
Does LQDA pay dividends?
Liquidia does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for LQDA?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for LQDA is Buy. The average 12-month price target is $53.13, a 24.6% upside from the Oct 23, 2026 close of $42.65.
What is the market cap of LQDA?
As of the Oct 23, 2026 close, Liquidia's market capitalization is $4.32B, classifying it as a mid-cap company. Liquidia operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.